Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (46)
Evelyn Kidess, Yvonne Giesecke, Ines Eichhorn, Raphael Mohr, Henning Jann, Christian Fischer, Bertram Wiedenmann, Christoph Roderburg, Frank Tacke & Michael Sigal. (2023) Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms. Journal of Cancer Research and Clinical Oncology 149:12, pages 10925-10933.
Crossref
Crossref
Roberta Elisa Rossi, Elisabetta Lavezzi, Simona Jaafar, Giacomo Cristofolini, Alice Laffi, Gennaro Nappo, Silvia Carrara, Alexia Francesca Bertuzzi, Silvia Uccella, Alessandro Repici, Alessandro Zerbi & Andrea Gerardo Antonio Lania. (2023) Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art. Cancers 15:16, pages 4065.
Crossref
Crossref
Michalis Koullouros, Fellicia Stanzah, Adam Swalling & Harsh Kanhere. (2022) Heterotopic pancreatic tissue masquerading as a neuroendocrine tumour. ANZ Journal of Surgery 92:12, pages 3353-3355.
Crossref
Crossref
Dimitrios Papantoniou, Malin Grönberg, Kalle Landerholm, Staffan Welin, Barbara Ziolkowska, Dennis Nordvall & Eva Tiensuu Janson. (2020) Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2. Endocrine 72:3, pages 893-904.
Crossref
Crossref
Catherine G. Tran, Scott K. Sherman, Aaron T. Scott, Po Hien Ear, Chandrikha Chandrasekharan, Andrew M. Bellizzi, Joseph S. Dillon, Thomas M. O’Dorisio & James R. Howe. (2020) It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors. Annals of Surgical Oncology 28:2, pages 732-741.
Crossref
Crossref
Magnus Kjellman, Ulrich Knigge, Staffan Welin, Espen Thiis-Evensen, Henning Gronbaek, Camilla Schalin-Jäntti, Halfdan Sorbye, Maiken Thyregod Joergensen, Viktor Johanson, Saara Metso, Helge Waldum, Jon Arne Søreide, Tapani Ebeling, Fredrik Lindberg, Kalle Landerholm, Goran Wallin, Farhad Salem, Maria del Pilar Schneider & Roger Belusa. (2021) A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors. Neuroendocrinology 111:9, pages 840-849.
Crossref
Crossref
Anna Malczewska, Magdalena Witkowska, Monika Wójcik-Giertuga, Katarzyna Kuśnierz, Agnes Bocian, Agata Walter, Mateusz Rydel, Amanda Robek, Sylwia Pierzchała, Magdalena Malczewska, Izabela Leś-Zielińska, Damian Czyżewski, Dariusz Ziora, Joanna Pilch-Kowalczyk, Wojciech Zajęcki & Beata Kos-Kudła. (2021) Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience. Neuroendocrinology 111:4, pages 304-319.
Crossref
Crossref
Nicola Fazio, Francesca Spada, Roberta Elisa Rossi, Valentina Ambrosini, Lorena Incorvaia, Francesco Passiglia, Massimiliano Cani & Giuseppe Badalamenti. 2021. Practical Medical Oncology Textbook. Practical Medical Oncology Textbook
1061
1089
.
Faidon-Marios Laskaratos, Man Liu, Anna Malczewska, Olagunju Ogunbiyi, Jennifer Watkins, Tu Vinh Luong, Dalvinder Mandair, Martyn Caplin & Christos Toumpanakis. (2020) Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection. Endocrine 69:2, pages 430-440.
Crossref
Crossref
Hendrik Rathke, Tim Holland-Letz, Walter Mier, Paul Flechsig, Eleni Mavriopoulou, Manuel Röhrich, Klaus Kopka, Markus Hohenfellner, Frederik Lars Giesel, Uwe Haberkorn & Clemens Kratochwil. (2020)
Response Prediction of
177
Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase
. Journal of Nuclear Medicine 61:5, pages 689-695.
Crossref
Crossref
Zhiyong Shi, Mingxia Zhang, Wenhui Yang & Jun Xu. (2020) Markedly Elevated HE4 in Hepatic Neuroendocrine Neoplasm: A Report of Two Cases and Literature Review. Hepatitis Monthly 20:3.
Crossref
Crossref
Anna Malczewska, Beata Kos-Kudła, Mark Kidd, Ignat Drozdov, Lisa Bodei, Somer Matar, Kjell Oberg & Irvin M. Modlin. (2020) The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors. Advances in Medical Sciences 65:1, pages 18-29.
Crossref
Crossref
Gitte Dam, Henning Grønbæk, Halfdan Sorbye, Espen Thiis Evensen, Björn Paulsson, Anders Sundin, Claus Jensen, Dyveke Ebbesen, Ulrich Knigge & Eva Tiensuu Janson. (2020) Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors. Neuroendocrinology 110:3-4, pages 217-224.
Crossref
Crossref
Somer Matar, Anna Malczewska, Kjell Oberg, Lisa Bodei, Harry Aslanian, Anna Lewczuk-Myślicka, Pier Luigi Filosso, Alejandro L. Suarez, Agnieszka Kolasińska-Ćwikła, Matteo Roffinella, Beata Kos-Kudła, Jarosław B. Ćwikła, Ignat A. Drozdov, Mark Kidd & Irvin M. Modlin. (2020) Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms. Neuroendocrinology 110:3-4, pages 185-197.
Crossref
Crossref
Roberta Elisa Rossi, Clorinda Ciafardini, Valentina Sciola, Dario Conte & Sara Massironi. (2018) Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms. Pancreas 47:10, pages 1249-1255.
Crossref
Crossref
Ivan Kruljac, Ivan Vurnek, Sebastian Maasberg, Davor Kust, Kristina Blaslov, Blaženka Ladika Davidović, Mario Štefanović, Alma Demirović, Alen Bišćanin, Jakša Filipović-Čugura, Jasmina Marić Brozić, Ulrich-Frank Pape & Milan Vrkljan. (2018) A score derived from routine biochemical parameters increases the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine neoplasms. Endocrine 60:3, pages 395-406.
Crossref
Crossref
Vincenzo Marotta, Maria Chiara Zatelli, Concetta Sciammarella, Maria Rosaria Ambrosio, Marta Bondanelli, Annamaria Colao & Antongiulio Faggiano. (2018) Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame. Endocrine-Related Cancer 25:1, pages R11-R29.
Crossref
Crossref
Vidya Aluri & Joseph S. Dillon. (2017) Biochemical Testing in Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 46:3, pages 669-677.
Crossref
Crossref
Michaela Bowden, Chensheng W. Zhou, Sui Zhang, Lauren Brais, Ashley Rossi, Laurent Naudin, Arunthi Thiagalingam, Ewa Sicinska & Matthew H. Kulke. (2017) Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma. Oncotarget 8:33, pages 54331-54344.
Crossref
Crossref
Masami Miki, Tetsuhide Ito, Masayuki Hijioka, Lingaku Lee, Kohei Yasunaga, Keijiro Ueda, Takashi Fujiyama, Yuichi Tachibana, Ken Kawabe, Robert T. Jensen & Yoshihiro Ogawa. (2017) Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors. Japanese Journal of Clinical Oncology 47:6, pages 520-528.
Crossref
Crossref
Stavros Gkolfinopoulos, Konstantinos Tsapakidis, Konstantinos Papadimitriou, Demetris Papamichael & Panteleimon Kountourakis. (2017) Chromogranin A as a valid marker in oncology: Clinical application or false hopes?. World Journal of Methodology 7:1, pages 9.
Crossref
Crossref
Marianne Pavel, Henning Jann, Vikas Prasad, Ignat Drozdov, Irvin M. Modlin & Mark Kidd. (2017) NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive. Neuroendocrinology 104:2, pages 170-182.
Crossref
Crossref
M. Raman. 2017.
199
244
.
Otto P. Rorstad. 2017. Endocrine Biomarkers. Endocrine Biomarkers
399
437
.
Fernando Fernández-Bañares, Anna Accarino, Agustín Balboa, Eugeni Domènech, Maria Esteve, Esther Garcia-Planella, Jordi Guardiola, Xavier Molero, Alba Rodríguez-Luna, Alexandra Ruiz-Cerulla, Javier Santos & Eva Vaquero. (2016) Diarrea crónica: definición, clasificación y diagnóstico. Gastroenterología y Hepatología 39:8, pages 535-559.
Crossref
Crossref
Fernando Fernández-Bañares, Anna Accarino, Agustín Balboa, Eugeni Domènech, Maria Esteve, Esther Garcia-Planella, Jordi Guardiola, Xavier Molero, Alba Rodríguez-Luna, Alexandra Ruiz-Cerulla, Javier Santos & Eva Vaquero. (2016) Chronic diarrhoea: Definition, classification and diagnosis. Gastroenterología y Hepatología (English Edition) 39:8, pages 535-559.
Crossref
Crossref
Margaret L. Burks & Shichun Bao. (2016) The 24-Hour Urinary 5-HIAA: A Simple Test With a Common Pitfall. AACE Clinical Case Reports 2:3, pages e186-e188.
Crossref
Crossref
Mark Kidd, Lisa Bodei & Irvin M. Modlin. (2016) Chromogranin A. Current Opinion in Endocrinology, Diabetes & Obesity 23:1, pages 28-37.
Crossref
Crossref
Irvin M. Modlin, Lisa Bodei & Mark Kidd. (2016) Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms. Best Practice & Research Clinical Endocrinology & Metabolism 30:1, pages 59-77.
Crossref
Crossref
Jarosław B. Ćwikła, Lisa Bodei, Agnieszka Kolasinska-Ćwikła, Artur Sankowski, Irvin M. Modlin & Mark Kidd. (2015) Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy. The Journal of Clinical Endocrinology & Metabolism 100:11, pages E1437-E1445.
Crossref
Crossref
Kjell Oberg, Irvin M Modlin, Wouter De Herder, Marianne Pavel, David Klimstra, Andrea Frilling, David C Metz, Anthony Heaney, Dik Kwekkeboom, Jonathan Strosberg, Timothy Meyer, Steven F Moss, Kay Washington, Edward Wolin, Eric Liu & James Goldenring. (2015) Consensus on biomarkers for neuroendocrine tumour disease. The Lancet Oncology 16:9, pages e435-e446.
Crossref
Crossref
Mark Kidd, Ignat Drozdov & Irvin Modlin. (2015) Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status. Endocrine-Related Cancer 22:4, pages 561-575.
Crossref
Crossref
I M Modlin, M Kidd, L Bodei, I Drozdov & H Aslanian. (2015) The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract. American Journal of Gastroenterology 110:8, pages 1223-1232.
Crossref
Crossref
Thorvardur R Halfdanarson, James R Howe, Sigurdis Haraldsdottir & Thomas M O'Dorisio. (2015) Circulating tumor markers in patients with neuroendocrine tumors – a clinical perspective. International Journal of Endocrine Oncology 2:1, pages 89-99.
Crossref
Crossref
Mark Kidd, Irvin M. Modlin, Lisa Bodei & Ignat Drozdov. (2015) Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology. Cellular and Molecular Gastroenterology and Hepatology 1:2, pages 131-153.
Crossref
Crossref
Apostolos Tsolakis & George Kanakis. 2015. Islets of Langerhans. Islets of Langerhans
1375
1406
.
Michela Del Prete, Francesco Fiore, Roberta Modica, Vincenzo Marotta, Francesca Marciello, Valeria Ramundo, Antonella Di Sarno, Annachiara Carratù, Chiara de Luca di Roseto, Salvatore Tafuto, Fabiana Tatangelo, Robero Baldelli, Annamaria Colao & Antongiulio Faggiano. (2014) Hepatic arterial embolization in patients with neuroendocrine tumors. Journal of Experimental & Clinical Cancer Research 33:1.
Crossref
Crossref
Irvin M Modlin, Ignat Drozdov, Lisa Bodei & Mark Kidd. (2014) Blood transcript analysis and metastatic recurrent small bowel carcinoid management. BMC Cancer 14:1.
Crossref
Crossref
Franco Grimaldi, Nicola Fazio, Roberto Attanasio, Andrea Frasoldati, Enrico Papini, Francesco Angelini, Roberto Baldelli, Debora Berretti, Sara Bianchetti, Giancarlo Bizzarri, Marco Caputo, Roberto Castello, Nadia Cremonini, Anna Crescenzi, Maria Vittoria Davì, Angela Valentina D’Elia, Antongiulio Faggiano, Stefano Pizzolitto, Annibale Versari, Michele Zini, Guido Rindi & Kjell Öberg. (2014) Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. Journal of Endocrinological Investigation 37:9, pages 875-909.
Crossref
Crossref
Irvin M Modlin, Ignat Drozdov, Daniele Alaimo, Stephen Callahan, Nancy Teixiera, Lisa Bodei & Mark Kidd. (2014) A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection. Endocrine-Related Cancer 21:4, pages 615-628.
Crossref
Crossref
J. Capdevila, A. Meeker, R. García-Carbonero, K. Pietras, A. Astudillo, O. Casanovas & A. Scarpa. (2013) Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets. Cancer and Metastasis Reviews 33:1, pages 345-351.
Crossref
Crossref
Anneke P.J. Jilesen, Olivier R.C. Busch, Thomas M. van Gulik, Dirk J. Gouma & Els J.M. Nieveen van Dijkum. (2014) Standard Pre- and Postoperative Determination of Chromogranin A in Resectable Non-Functioning Pancreatic Neuroendocrine Tumors - Diagnostic Accuracy: NF-pNET and Low Tumor Burden. Digestive Surgery 31:6, pages 407-414.
Crossref
Crossref
Irvin M. Modlin, Kjell Oberg, Andrew Taylor, Ignat Drozdov, Lisa Bodei & Mark Kidd. (2014) Neuroendocrine Tumor Biomarkers: Current Status and Perspectives. Neuroendocrinology 100:4, pages 265-277.
Crossref
Crossref
Apostolos Tsolakis & George Kanakis. 2013. Islets of Langerhans, 2. ed.. Islets of Langerhans, 2. ed.
1
29
.
Federica Braga, Simona Ferraro, Roberta Mozzi, Alberto Dolci & Mauro Panteghini. (2013) Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase. Clinical Biochemistry 46:1-2, pages 148-151.
Crossref
Crossref
George Kanakis & Gregory Kaltsas. (2012) Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Best Practice & Research Clinical Gastroenterology 26:6, pages 791-802.
Crossref
Crossref